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Introduction
Reliable models of LPS-induced inflammation are
lacking for many species important in veterinary
medicine.  In the absence of models with reliable
biomarkers of inflammation, it is difficult to sub-
stantiate anti-inflammatory claims for new drugs
in these species. Non-steroidal anti-inflammatory
drugs (NSAIDs) represent a common class of drugs
used to treat inflammation in a variety of species.
NSAIDs reduce fever, pain and inflammation in
both animals and people by inhibiting
prostaglandin synthesis (Lees et al., 2004). Evi-
dence that models for inflammation are lacking can
be seen in that only one NSAID, flunixin meglu-
mine (Banamine; Schering-Plough), is currently
approved by the FDA to control endotoxin-induced
inflammation, pyrexia and the inflammation and
pain associated with musculoskeletal disorders.
The approval of flunixin meglumine by the FDA
was based on claims that thromboxane B2 (TXB2)
and prostaglandin E2 (PGE2) synthesis were re-
duced by the drug in two different models: a sys-
temic endotoxemic inflammation model and a
bovine soft tissue model of inflammation (U.S.
Food and Drug Administration, 1998).  Evidence
for the control of inflammation through reduction
in eicosanoid production was derived from pub-
lished literature studies not conducted under the
drug review process.
Identifying and verifying biomarkers for in-
flammation in species would expedite the discov-
ery, evaluation and drug approval process for new
NSAIDs. Previous work in this area identified in
vitro inflammatory biomarkers in swine utilizing a
genomic approach (Peters et al., 2011). 
Some of the previously identified biomarkers
for inflammation in swine might prove to be uni-
versal across species as reliable biomarkers for in-
flammation due to similarities in the physiological
responses to inflammation in many veterinary
species. This study aims to correlate expression
patterns identified in the aforementioned study with
those observed in LPS-stimulated bovine, ovine
and equine whole blood cultures. The knowledge
gained will help to ascertain if there are universal
genetic biomarkers. A single set of biomarkers
common to multiple species would aid in verifying
the efficacy of novel NSAIDs by presenting a uni-
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Abstract
There are currently no validated animal models or suitable biomarkers with which to ascertain the efficacy of non-steroidal
anti-inflammatory drugs (NSAIDs) in equine, bovine or ovine species during conditions of endotoxemia. This has resulted
in approval of only one NSAID, flunixin meglumine, for controlling inflammation due to endotoxemia in bovine and equine
animals, while none are approved in ovine animals for this claim. This study aims to investigate biomarkers with which to
test efficacy of NSAIDs in these species. To this end, the effects of Escherichia coli lipopolysaccharide (LPS) induced in-
flammation on gene expression were investigated. Whole blood from each species was cultured and stimulated with LPS,
after which RNA was extracted at various times. RNA was analyzed via quantitative RT-PCR (qRT-PCR) to determine dif-
ferential expression of biomarkers. Results indicated up-regulation of cluster of differentiation 1 (CD1) gene in bovine and
serum amyloid A (SAA) gene in ovine cultures. Down-regulation of cluster of differentiation 4 (CD4) gene and Caspase 1
was seen in bovine, and of CD1 in equine cultures. This work demonstrates that LPS stimulation alters expression of these
genes in these species. These genes may be useful biomarkers for inflammation which could serve as markers for NSAID ef-
ficacy. 
Keywords: Inflammation; biomarker; LPS; equine, bovine, ovine
Original Research
ISSN: 2090-6277/2090-6269, www.advancedvetresearch.com
versal test with which to analyze the drugs. 
Materials and methods
Blood Collection and Treatment:
Bovine, equine and ovine blood were obtained
from Bioreclamation, Inc. (Hicksville, NY). Blood
was collected from 5 animals of each species to be
utilized in qRT-PCR analysis. Ultraculture media
(Lonza, Walkersville, MD) was supplemented with
L-glutamine (20mM), gentamicin (50µg/ml),
HEPES (10mM), sodium bicarbonate (0.075%)
and amphotericin B (0.25 µg/ml). The fortified
media was used to dilute the blood samples to a 1:1
ratio, starting with approximately 15 ml of blood
in each flask (final volume 30 ml per flask; Nal-
gene-Nunc, Rochester, NY). A concentration of 1
µg/ml lipopolysaccharide E. coli O55:B5 (Sigma-
Aldrich, St. Louis, MO) was used to stimulate the
whole blood cultures at 24 and 48 hours. Unstim-
ulated 0 h, 24 h and 48 h control cultures were also
employed.
RNA Isolation:
The LeukoLock Total RNA Isolation kit (Ambion,
Austin, TX) was utilized to extract RNA from
whole blood cultures of the different species ac-
cording to the manufacturer’s protocol with minor
modifications.  Briefly, a 10 cc syringe was con-
nected directly to a LeukoLock filter and used to
flush approximately 15 ml of blood through the fil-
ter. The filters were then each flushed with 3 ml of
PBS, followed by 3 ml of RNAlater and 2.5 ml of
pH-adjusted Lysis/Binding Solution. Twenty-five
µl of proteinase K was then used to treat the col-
lected lysate. RNA isolation was performed using
RNA binding beads. Samples were incubated and
centrifuged, after which the beads were transferred
to a clean microcentrifuge tube. Next, a series of
wash steps was performed to purify the product.
RNA was recovered in 40 µl of elution buffer and
was quantified using a NanoDrop spectrophotome-
ter (Thermo Fisher Scientific, Wilmington, DE).
The RNA samples were normalized to a concentra-
tion of 50 ng/µl for qRT-PCR analysis. 
Real-time RT-PCR:
Custom primers (Table 1) were designed for the
tested species using Allele ID (PREMIER Biosoft
International, Palo Alto, CA) and synthesized by
Integrated DNA Technologies (Coralville, IA).
Quantitative real-time RT-PCR (qRT-PCR) was
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Table 1. Selected genes differentially expressed in leukocytes from whole blood post-LPS treatment
performed with these primers using the Mastercy-
cler® ep Realplex (Eppendorf, Hamburg, Ger-
many). The SuperScript III Platinum Sybr Green
One-Step qRT-PCR Kit (Invitrogen, Carlsbad, CA)
was utilized for qRT-PCR analysis of samples. The
master mix used was comprised of 25 µl of 2X
Sybr Green Reaction Mix, 21 µl of DEPC-treated
water,1 µl of Platinum Taq Mix, and 1 µl each of
forward and reverse primers at a concentration of
10 µM, with 50 ng of the total RNA sample. The
thermocycling parameters were: cDNA synthesis
at 50ºC for 3 min, 95ºC for 5 min, then 40 cycles
of 95ºC for 15 sec, 60ºC for 30 sec and 60ºC for 30
sec. 
Statistical Analysis: 
The delta-delta Ct method was used to assess rela-
tive expression of genes with GAPDH as the nor-
malizing gene. Data are presented as mean ± SEM.
Comparison of qRT-PCR data across samples to
their respective 0h values was done by performing
a Friedman test. Both the 24h and 24h control, and
the 48h and 48h control data were compared using
the Wilcoxon signed rank test. Statistical signifi-
cance was considered to be a P value < 0.0625
based on small sample size. 
Results
GAPDH specific to each species was utilized as a
reference gene for the study to establish the meta-
bolic activity of the cells. No significant change in
GAPDH expression was observed due to time or
LPS treatment in any of the species (Fig. 1).
Ovine (Fig. 2) and equine (Fig. 3) whole blood
cultures demonstrated significant up-regulation as
compared to the 0 hour time point for monocyte
chemoattractant protein-1 (MCP-1). Significance 
between LPS-stimulated and control samples at
each time point was not obtained in either species
due to extreme variability in expression of the
gene.
The cluster of differentiation 1 (CD1) gene was
evaluated in two of the three species.  CD1 was not
analyzed in ovine samples due to the lack of ovine-
specific sequence information for the gene. Expres-
sion of CD1 differed between equine and bovine
cultures. CD1 was up-regulated with statistical sig-
nificance at all time points through 48 hours in the
bovine blood. The 24h LPS-stimulated culture was
significantly less up-regulated than the 24c culture
(Fig. 4). Conversely, marked down-regulation of
the gene is evident in equine blood over time. The
stimulated 48h culture was significantly more
down-regulated than the 48c culture (Fig. 5).
Expression of the cluster of differentiation 4
(CD4) gene shows down-regulation at all time
points in bovine and equine cultures (Fig. 6).
Ovine expression of CD4 showed the opposite
trend with up-regulation through the 48 hour time
point (Fig. 7).  Bovine samples for 24h and 24c
were also statistically different showing less down-
regulation in the presence of LPS.
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Equine and bovine blood cultures demonstrated
significant down-regulation of Caspase 1 at all time
points relative to the 0 hour time point (Fig. 8).
Bovine Caspase 1 indicated a statistically different
response between the 24h and 24c time points with
less down-regulation in the presence of LPS.
Analysis of serum amyloid A 3 (SAA3) gene 
expression in the ovine blood cultures showed sig-
nificant up-regulation of the gene through 48 hours
(Fig. 9). A statistically significant difference was
also noted with the 24h time point showing more
elevated expression than the 24c time point. 
Discussion
The candidate biomarkers analyzed in this study
have all been previously identified as components
of inflammatory or immune responses (Table 1).
MCP-1 is the primary chemoattractant for recruit-
ment of monocytes during the inflammatory re-
sponse (Maus et al., 2002). The lack of significance
between the control and LPS-stimulated samples
indicates that there is no consistent effect of LPS
treatment in culture that might not also be seen
solely due to time in culture. Use of MCP-1 as a
biomarker would not be advisable based on the un-
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reliability of results caused by this variation. 
CD1 is involved in antigen recognition by T
cells during the immune response (Porcelli et al.,
1989). Bovine RNA indicated that CD1 was up-
regulated with statistical significance at all time
points through 48 hours. The significance found
between the 24h LPS-stimulated culture and the
24c culture demonstrates that this change would
not have happened simply due to time in culture.
Conversely, marked down-regulation of the gene is
evident in equine blood over time. The stimulated
48h culture was significantly more down-regulated
than the 48c culture which also demonstrates a
change not solely due to time in culture. The dif-
ferences in expression of CD1 between equine and
bovine cultures were not unexpected as previously
there have been conflicting reports about the ex-
pression of CD1.
Previous studies indicate that there is a localized
up-regulation of CD1 subsets that, it has been pro-
posed, may suggest that there is a pro-inflamma-
tory positive feedback loop involving dendritic
cells that express CD1 and CD1 restricted T cells
(Vincent et al., 2002). CD1 has also been reported
to be down-regulated in a number of studies fol-
lowing in vitro exposure to Mycobacteria
(Gagliardi et al., 2004, 2007; Mariotti et al., 2004;
Stenger et al., 1999). Peters et al. (2011) also found
that CD1 was down-regulated in swine whole
blood cultures as a result of LPS exposure, leading
them to conjecture that the differences in CD1 ex-
pression may result from different signal transduc-
tion pathways initiated by the different pathogens,
or pathogen components, being studied. Our find-
ings also might suggest that there is a difference in
CD1 expression based on species differences. The
down-regulation of CD1 seen in the equine blood
in our study has also been observed in equine pe-
ripheral blood adherent cells (PBAC) which sug-
gests that Rhodococcus equi infection results in
down-regulation of CD1b (Pargass et al., 2009).
This information could allow for the contention
that it may be the species of animal rather than, or
in addition to, the pathogen that accounts for the
difference in CD1 gene expression. There are un-
accounted for differences in CD1 regulation be-
tween the equine and bovine which indicate that
the response of CD1 to inflammation may not be
universal across species. However, it may serve as
a useful biomarker if differences between each
species are taken into account.
Expression patterns for CD4, which is involved
in the development and activation of helper T cells
for the immune response (Zamoyska, 1998), were
measured in all three species. The gene was down-
regulated at all time points in bovine and equine
cultures showing that the gene does change over
time. Ovine expression of CD4 also showed a
change with up-regulation through the 48 hour time
point. Bovine samples for 24h and 24c were the
only ones demonstrating a statistical difference
showing less down-regulation in the presence of
LPS, and indicating that the change was not a result
of time in culture. This leads us to believe that CD4
may be an effective biomarker for inflammation in
bovine through the 24 hour time point.
Caspase 1 is involved in regulation of apoptosis
(Earnshaw et al., 1999) and initiation of a pathway
that results in expression and secretion of inter-
leukin-1beta (IL-1β) and IL-18 during inflamma-
tion (Tschopp and Schroder, 2010). The statistical
difference in bovine RNA between the 24h and 24c
time points suggests that the gene may be an effec-
tive bovine biomarker for inflammation when ana-
lyzing to the 24h time point.
SAA proteins are involved in the acute-phase
response to inflammation both in up- and down-
regulating genes and processes involved in the in-
flammatory response (Malle et al., 1993). The
statistically significant difference noted at the 24h
time point in ovine cultures demonstrates that LPS
treatment has an effect on the expression of SAA3
and is not being caused solely by time in culture.
This resembles the finding that SAA2 is up-regu-
lated at all time points in swine with significance
by the 24h time point and a statistically significant
difference between the LPS-stimulated and control
samples at that point in time (Peters et al., 2011).
This pattern indicates that SAA may be a bio-
marker for inflammation in swine and ovine.
In summary, we have demonstrated that a subset
of the in vitro biomarkers identified in swine is also
indicative of LPS-stimulated inflammation in
bovine, ovine and equine whole blood culture in
vitro. Specifically, these are CD1, CD4 and Cas-
pase 1 in bovine; SAA3 in ovine and CD1 in
equine cultures. The similarities in expression of
these genes between species makes them potential
candidates for use in testing anti-inflammatory
drugs in a species to assess the effects of the drugs
against the expression of these candidate biomark-
ers in response to inflammation. Further study of
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the response of these genes in the presence of
NSAIDs as well as in vivo will be necessary to
firmly establish this relationship. This work may
assist in the development of a model to study in-
flammation and test anti-inflammatory drugs more
efficiently in vivo. Our findings indicate that it may
not be possible for a single genetic marker to serve
as a universal biomarker for all species. However,
some of the genes may prove to be useful biomark-
ers for inflammation within a given species.
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